Consolidated Balance Sheets (Not Reviewed) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 13,987	$ 1,077
Accounts receivables	2,661	2,621
Discount on convertible notes	4,808	0
Other receivables	794,095	0
Related party loan	571,669	514,788
Total current assets	1,387,220	518,486
Property, plant and equipment, net of accumulated depreciation and amortization	91,786	95,896
Deferred tax asset	103,905	98,727
Total non-current assets	195,691	194,623
Total assets	1,582,911	713,109
Liabilities
Accounts payables	281,744	286,137
Convertible notes	61,967	0
Derivative liabilities	147,123	0
Accrued and other liabilities	130,254	138,980
Long-term debt – current position	29,892	49,147
Line of credit	180,316	187,983
Total current liabilities	831,296	662,247
Long-term debt – non-current position	0	0
Total non-current liabilities	0	0
Total liabilities	831,296	662,247
Equity
Common stock Authorized: $0.001 par value, 290,000,000 shares authorized Issued and outstanding: 26,711,000 and 73,590,730, respectively	77,326	123,953
Additional paid in capital	4,373,467	3,442,920
Preference Stock Authorized: $0.001 par value, 10,000,000 shares authorized Issued and outstanding: 2,600,000 and 0 Nil, respectively	2,600	0
Adjustments to equity to reflect retroactive application of reverse acquisition of accounting	(53,511)	(53,511)
Accumulated losses	(3,547,109)	(3,487,866)
Foreign currency translation differences	(101,158)	25,366
Total stockholders’ surplus/(deficit)	751,615	50,862
Total liabilities and stockholders’ equity	$ 1,582,911	$ 713,109